BlackRock’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33M | Sell |
2,405,241
-18,222
| -0.8% | -$250K | ﹤0.01% | 2686 |
|
2025
Q1 | $26.8M | Sell |
2,423,463
-43,748
| -2% | -$484K | ﹤0.01% | 2732 |
|
2024
Q4 | $26.3M | Sell |
2,467,211
-30,732
| -1% | -$327K | ﹤0.01% | 2829 |
|
2024
Q3 | $31.7M | Buy |
2,497,943
+303,993
| +14% | +$3.86M | ﹤0.01% | 2711 |
|
2024
Q2 | $36.8M | Buy |
2,193,950
+477,137
| +28% | +$8.01M | ﹤0.01% | 2555 |
|
2024
Q1 | $25.8M | Sell |
1,716,813
-2,491
| -0.1% | -$37.4K | ﹤0.01% | 2787 |
|
2023
Q4 | $25.8M | Buy |
1,719,304
+521,657
| +44% | +$7.82M | ﹤0.01% | 2810 |
|
2023
Q3 | $16.8M | Buy |
1,197,647
+99,731
| +9% | +$1.4M | ﹤0.01% | 2993 |
|
2023
Q2 | $11.4M | Buy |
1,097,916
+813,377
| +286% | +$8.42M | ﹤0.01% | 3292 |
|
2023
Q1 | $2.63M | Sell |
284,539
-64,731
| -19% | -$598K | ﹤0.01% | 3845 |
|
2022
Q4 | $3.1M | Buy |
349,270
+4,492
| +1% | +$39.8K | ﹤0.01% | 3867 |
|
2022
Q3 | $2.87M | Buy |
344,778
+4,366
| +1% | +$36.3K | ﹤0.01% | 3930 |
|
2022
Q2 | $2.79M | Sell |
340,412
-1,360,364
| -80% | -$11.1M | ﹤0.01% | 4008 |
|
2022
Q1 | $14.8M | Sell |
1,700,776
-27,318
| -2% | -$238K | ﹤0.01% | 3290 |
|
2021
Q4 | $16.4M | Buy |
1,728,094
+15,871
| +0.9% | +$151K | ﹤0.01% | 3331 |
|
2021
Q3 | $28.8M | Sell |
1,712,223
-14,816
| -0.9% | -$249K | ﹤0.01% | 2997 |
|
2021
Q2 | $26.4M | Buy |
1,727,039
+56,434
| +3% | +$862K | ﹤0.01% | 3080 |
|
2021
Q1 | $32.5M | Buy |
1,670,605
+141,114
| +9% | +$2.75M | ﹤0.01% | 2855 |
|
2020
Q4 | $27.6M | Buy |
1,529,491
+43,890
| +3% | +$791K | ﹤0.01% | 2776 |
|
2020
Q3 | $28.7M | Buy |
1,485,601
+19,796
| +1% | +$382K | ﹤0.01% | 2592 |
|
2020
Q2 | $38.3M | Buy |
1,465,805
+68,829
| +5% | +$1.8M | ﹤0.01% | 2374 |
|
2020
Q1 | $24.9M | Buy |
1,396,976
+24,113
| +2% | +$430K | ﹤0.01% | 2456 |
|
2019
Q4 | $45.8M | Sell |
1,372,863
-22,067
| -2% | -$736K | ﹤0.01% | 2394 |
|
2019
Q3 | $33.2M | Buy |
1,394,930
+56,377
| +4% | +$1.34M | ﹤0.01% | 2508 |
|
2019
Q2 | $48.1M | Buy |
1,338,553
+915,970
| +217% | +$32.9M | ﹤0.01% | 2318 |
|
2019
Q1 | $15.6M | Buy |
422,583
+122,554
| +41% | +$4.53M | ﹤0.01% | 2858 |
|
2018
Q4 | $12.9M | Buy |
300,029
+197,410
| +192% | +$8.5M | ﹤0.01% | 2942 |
|
2018
Q3 | $4.85M | Buy |
102,619
+12,829
| +14% | +$606K | ﹤0.01% | 3471 |
|
2018
Q2 | $4.47M | Buy |
+89,790
| New | +$4.47M | ﹤0.01% | 3492 |
|